We are live on ! Find out more
NXL icon

Nexalin Technology

19 hedge funds and large institutions have $1.04M invested in Nexalin Technology in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

262% more capital invested

Capital invested by funds: $287K → $1.04M (+$752K)

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

27% more funds holding

Funds holding: 1519 (+4)

1.22% less ownership

Funds ownership: 4.05%2.83% (-1.2%)

Holders
19
Holders Change
+4
Holders Change %
+26.67%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
6
Reduced
1
Closed
7
Calls
Puts
Net Calls
Net Calls Change

NXL Hedge Fund Activity: Q4 2024 in Review

19 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Nexalin Technology (NXL) for Q4 2024, worth a combined $1.04M — up 262% from $287K a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new NXL positions and 7 closed out — a net gain of 4 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $261K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $68.8K sold.

  • 19 institutional investors held Nexalin Technology (NXL) as of Q4 2024, up from 15 in Q3 2024.
  • Funds reported $1.04M of Nexalin Technology stock for Q4 2024, up 262% quarter-over-quarter.
  • 11 funds opened new Nexalin Technology positions in Q4 2024 and 7 closed out, a net change of +4 holders.
  • The largest Nexalin Technology buyer in Q4 2024 was Vanguard Group, an estimated $261K added.
  • The largest Nexalin Technology seller in Q4 2024 was Renaissance Technologies, an estimated $68.8K sold.

Based on aggregated 13F filings for Q4 2024.